Swiss Institute for Medical Cannabis Research
Advancing Patient-Centered Cannabinoid Therapies Through Clinical Research and Physician Education
SIMCR is a Swiss nonprofit scientific institute dedicated to bridging clinical research and physician education in cannabinoid medicine. We equip healthcare professionals with rigorous, evidence-based knowledge to safely integrate cannabinoid therapeutics into medical practice.
Why This Matters
The Gap Between Science and Practice
Cannabinoid science is advancing rapidly, but physician knowledge hasn't kept pace. Most medical professionals lack formal training on the endocannabinoid system or how to integrate cannabinoid therapeutics safely into practice.
This creates real barriers:
- Physicians aren't trained to prescribe cannabinoid-based treatments
- Clinical evidence is fragmented across research communities
- Patients lack access to supervised, evidence-based care
- Treatment frameworks aren't standardized or safe
SIMCR was established to close this gap through structured research, rigorous education, and clinical pathways.
Two Pillars
Our Two Core Pillars
SIMCR operates at the intersection of research, education, and patient-centered care through two core pillars.
The institute also functions within a broader ecosystem of scientific, educational, and collaborative initiatives that support its long-term research, clinical, and institutional objectives.
Education
SIMCR Academy
Providing CME-certified physician education on cannabinoid medicine and the endocannabinoid system.
Our programs equip healthcare professionals with clinically relevant knowledge, enabling safe and responsible integration of cannabinoid therapeutics into their practice.
Clinical Research
Patient-Centered Research
Designing and conducting clinical research that generates real-world evidence on full-spectrum cannabinoid therapeutics.
Our protocols prioritize patient safety, medically supervised care, and clinically meaningful outcomes, creating credible evidence that advances responsible clinical practice.
Swiss Institutional Standards
Why Swiss Standards Matter
SIMCR operates as a Swiss scientific institute, which means we're held to rigorous European regulatory, ethical, and governance standards. This isn't just bureaucracy - it's what gives our research and education credibility. Every protocol, dataset, and training program reflects Swiss clinical rigor.
- Scientific rigor applied to every research activity
- Methodological transparency and data integrity
- Patient safety and medically supervised care within all clinical protocols
- Governance and compliance aligned with Swiss regulatory standards
- Ethical oversight and institutional accountability across research and education
Selective Partnerships
Collaborate With Us
SIMCR works with a limited number of scientifically and clinically aligned partners. We engage with physicians, researchers, academic institutions, and medical educators whose methodology, clinical standards, and commitment to patient-centered science are consistent with our own.
In practice, collaboration with SIMCR means co-developing clinical research protocols, contributing to physician training programs within the SIMCR Academy, and participating in structured data and evidence frameworks.
We prioritize partnerships that contribute directly to:
- Co-developing structured clinical research protocols
- Contributing to physician education and CME-certified training
- Generating and sharing high-quality clinical data
- Integrating endocannabinoid science into clinical practice
Supporting the Mission
As a nonprofit scientific institute, SIMCR relies on individual and organizational support. Your contributions directly fund clinical research, physician education, and evidence-based integration of cannabinoid medicine into healthcare.
Interested in Supporting SIMCR's Research?
Support enables:
- Development and execution of clinical research protocols
- Data collection, analysis, and publication
- Patient access to supervised cannabinoid-based treatments within research frameworks
- Provision of standardized cannabinoid formulations used within clinical research
- Expansion of educational programs through the SIMCR Academy
- Development of institutional, operational, and compliance infrastructure